Tuis04K • FRA
add
Knight Therapeutics Inc
Vorige sluiting
€3,64
Dagwisseling
€3,72 - €3,72
Jaarwisseling
€3,40 - €4,10
Markkapitalisasie
577,84 m CAD
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
TSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 88,08 m | 1,70% |
Bedryfskoste | 40,40 m | 3,49% |
Netto inkomste | 2,18 m | 148,06% |
Netto winsgrens | 2,48 | 147,24% |
Wins per aandeel | 0,02 | 150,00% |
EBITDA | 6,05 m | -60,32% |
Effektiewe belastingkoers | 647,62% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 180,86 m | -5,84% |
Totale bates | 1,00 mjd | 3,60% |
Totale aanspreeklikheid | 207,60 m | 0,62% |
Totale ekwiteit | 795,44 m | — |
Uitstaande aandele | 99,63 m | — |
Prys om te bespreek | 0,46 | — |
Opbrengs op bates | -1,41% | — |
Opbrengs op kapitaal | -1,63% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 2,18 m | 148,06% |
Kontant van bedrywe | 3,67 m | -88,12% |
Kontant van beleggings | 32,13 m | 231,85% |
Kontant van finansiering | -4,70 m | -62,20% |
Netto kontantverandering | 32,05 m | 686,67% |
Beskikbare kontantvloei | -7,56 m | -883,33% |
Meer oor
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Gestig
2014
Hoofkwartier
Webwerf
Werknemers
745
